BBI Life Sciences Corporation reported audited consolidated earnings results for the year ended December 31, 2016. For the period, the company has posted revenue of RMB 352,026,000 against RMB 282,390,000 a year ago. Operating profit was RMB 64,935,000 against RMB 52,079,000 a year ago. Profit before income tax was RMB 70,644,000 against RMB 57,555,000 a year ago. Profit for the year was RMB 59,093,000 against RMB 50,348,000 a year ago. Total profit attributable to equity holders of the company was RMB 60,183,000 or 0.111 per basic and diluted share against RMB 50,344,000 or 0.093 per diluted share a year ago. Net cash generated from operating activities was RMB 79,278,000 against RMB 87,460,000 a year ago. The expenditure incurred in purchasing property, plant and equipment and of construction in process amounted to RMB 128.89 million.